GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of my ALT moved and I cannot work out whether dual agonist is why — 44 comments in the full submission. View in context.
1.9k
c/survodutide·submitted 10 months ago by u/thermal_mass_tom

my ALT moved and I cannot work out whether dual agonist is why

Discussionbranch of 8 comments

Something I keep coming back to: my ALT moved and I cannot work out whether dual agonist is why. Imaging-derived liver fat fraction is a surrogate. It correlates with histology imperfectly, and a trial reporting one is not reporting the other. Nothing containing this compound is approved anywhere. Research-use-only…

Read the full submission and all 44 comments →

This branch

8 comments, started 10 months ago
u/injection_site_iris248 points·10 months ago

Histological endpoints in this field are scored on biopsy: resolution of steatohepatitis without worsening of fibrosis, or improvement in fibrosis without worsening of steatohepatitis. Both are harder to achieve and to interpret than an imaging surrogate.

replysharereportpermalink
[deleted]111 points·10 months ago

[deleted]

replysharereportpermalink
u/refund_ledger26 points·10 months ago

not approved anywhere, and the boards forget that constantly

replysharereportpermalink
load more comments (1) →
u/valeria_karlsen128 points·10 months ago

That is an escalation schedule for an unapproved compound and this board does not host those.

replysharereportpermalink
u/vitamin_d_void45 points·10 months ago

glucagon agonism and energy expenditure is the mechanistic thread

replysharereportpermalink
load more comments (2) →

← back to the whole thread

About c/survodutide

Survodutide-specific discussion: glucagon-receptor co-agonism, the hepatic fat and MASH resolution data, and how the side-effect profile compares with GIP-based dual agonism. Small community, high signal.

12kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/survodutide rules
  1. Glucagon co-agonism has a distinct safety story. Do not generalise from tirzepatide.
  2. MASH claims need the trial and the biopsy endpoint.
  3. Not approved. Descriptive posts only.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.